Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor Agonist.
ACS Med Chem Lett. 2020 Dec 17;12(1):115-120. doi: 10.1021/acsmedchemlett.0c00561. eCollection 2021 Jan 14.
ACS Med Chem Lett. 2020.
PMID: 33488972
Free PMC article.